Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Interferon α 2b Pharmacovigilance Study [Phase 4]
A Phase 4 pharmacovigilance trial evaluating Interferon alfa-2b in chronic hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Improving Hepatitis C Treatment in Injection Drug Users [Phase 4]
This update reports the completion of a Phase 4 trial evaluating strategies to improve Hepatitis C treatment among injection drug users.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir [Phase 1]
Phase 1 study examining pharmacokinetic interactions between telaprevir and un-boosted atazanavir in adults with chronic hepatitis C and HIV…
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: VX-950-TiDP24-C219: A Roll Over Trial for Patients in the Control Group of the C216 Study Who Received Telaprevir Placebo [Phase 3]
This is a completed Phase 3 rollover trial (VX-950-TiDP24-C219) for Hepatitis C in which patients in the control group of the C216 study rec…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing. [Phase 1]
Phase I study evaluating drug-drug interaction between TMC435350 and rifampin after multiple dosing in Hepatitis C patients.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease [NA]
This clinical trial update reports on polymorphisms of fibrosis-related genes and their association with outcomes in hepatitis C-related chr…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients [Phase 4]
Clinical trial update describing a Phase 4 study evaluating nitazoxanide, interferon alfa, and ribavirin for hepatitis C in patients with ty…
-
CLINICAL_TRIALS research · 2013-04-17Clinical Trial Update: Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients
Clinical trial exploring predictors of response to combined pegylated interferon and ribavirin in adults with chronic hepatitis C in Egypt.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients [Phase 2]
Phase 2 trial evaluating tacrolimus-based immunosuppression with steroids versus a monoclonal anti-IL2R antibody in hepatitis C–positive liv…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: TMC435-TiDP16-C112 - Interaction Trial With Antidepressants [Phase 1]
Phase 1 interaction trial evaluating telaprevir (TMC435) with antidepressants in hepatitis C patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration [Phase 1]
A Phase 1 study comparing two new capsule formulations of TMC435 with an established capsule and assessing blood levels after a single dose …
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Completed post-marketing surveillance study P04584 evaluated treatment with PegIntron Pen and Rebetol in HIV-infected patients with chronic …
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver Transplantation [Phase 2]
A Phase 2 clinical trial evaluating pre-transplant treatment to prevent hepatitis C recurrence after liver transplantation has completed, wi…
-
CLINICAL_TRIALS trial_result · 2013-04-01Clinical Trial Update: A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies [Phase 2]
A Phase 2 follow-up trial to assess resistance to ABT-072 in subjects with hepatitis C who previously received ABT-072; the study is complet…
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients [Phase 3]
Phase 3 trial evaluating whether escitalopram prevents pegylated interferon–associated depression in hepatitis C patients; results have been…
-
CLINICAL_TRIALS research · 2013-03-18Clinical Trial Update: Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment [Phase 2]
Phase II clinical trial evaluating silymarin for chronic hepatitis C in patients who failed conventional antiviral therapy has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123) [Phase 1]
This Phase 1 pharmacokinetic study evaluated whether Boceprevir affects plasma concentrations of methadone or buprenorphine/naloxone in pati…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: 100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC) [Phase 4]
A Phase 4 trial in Korean patients with chronic hepatitis C reported sustained virologic response rates of 100% versus 80% for Pegasys.
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected Patients [Phase 1]
This is a first-in-human Phase 1 trial that assessed safety, tolerability, and pharmacokinetics of increasing single and repeated oral doses…
-
CLINICAL_TRIALS withdrawal · 2013-02-26Clinical Trial Update: A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection [Phase 3]
A Phase 3 trial of BI201335 for chronic hepatitis C in treatment-naive and relapsed patients has been withdrawn, with no results reported.
-
CLINICAL_TRIALS trial_result · 2013-02-20Clinical Trial Update: A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382 [Phase 1]
Phase 1 study in healthy participants evaluating safety, tolerability, and plasma pharmacokinetics of single oral doses of JNJ-47910382; the…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: A Study Evaluating the Safety and Clinical Activity of HCV-796 in Treatment-Naive and Non-Responder Subjects [Phase 2]
A completed Phase 2 study evaluating the safety and clinical activity of HCV-796 in treatment-naive and non-responder patients with Hepatiti…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C [Phase 1, Phase 2]
This clinical trial update reports completion of a Phase I/II study evaluating interferon alfa-5 in treatment-experienced patients with geno…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Ypeginterferon Alfa-2b in chronic hepatitis C has been completed.
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis [Phase 1]
This Phase 1 pharmacokinetic study evaluated raltegravir in HIV/HCV coinfected patients with advanced hepatic cirrhosis (Child-Pugh C) to ch…